186830-98-8 Usage
Uses
Used in Pharmaceutical Industry:
5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID 9& is used as a building block in the synthesis of various pharmaceutical products for its potential therapeutic applications. Its anti-inflammatory and antioxidant properties make it a candidate for the development of treatments for different diseases and conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID 9& is utilized as a component in the creation of agrochemical products, potentially contributing to the development of new pesticides or other agricultural chemicals that can enhance crop protection and yield.
Used in Biomedical Applications:
5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID 9& is being investigated for its role in the development of new materials for biomedical applications, suggesting its potential use in creating innovative solutions for medical and healthcare needs.
Used in Research and Development:
5-(2 5-DICHLOROPHENYL)-2-FUROIC ACID 9& is also used in research and development settings to explore its potential uses further, including its anti-inflammatory and antioxidant properties, and to understand its implications in various fields of study.
Check Digit Verification of cas no
The CAS Registry Mumber 186830-98-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,6,8,3 and 0 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 186830-98:
(8*1)+(7*8)+(6*6)+(5*8)+(4*3)+(3*0)+(2*9)+(1*8)=178
178 % 10 = 8
So 186830-98-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H6Cl2O3/c12-6-1-2-8(13)7(5-6)9-3-4-10(16-9)11(14)15/h1-5H,(H,14,15)
186830-98-8Relevant articles and documents
Discovery of new C3aR ligands. Part 1: Arginine derivatives
Denonne, Frederic,Binet, Sophie,Burton, Maggi,Collart, Philippe,Dipesa, Alan,Ganguly, Tanmoy,Giannaras, Alexander,Kumar, Seema,Lewis, Timothy,Maounis, Florence,Nicolas, Jean-Marie,Mansley, Tamsin,Pasau, Patrick,Preda, Dorin,Stebbins, Karin,Volosov, Alexander,Zou, Dong
, p. 3258 - 3261 (2008/02/08)
The synthesis and in vitro binding of several new arginine-containing C3aR ligands are reported. DMPK properties and functional activities of selected compounds have been evaluated. One compound is shown to be active in an in vivo model of airway inflamma